Compare ARK Genomic Revolution ETF (ARKG) vs ZIM Integrated Shipping Services Ltd (ZIM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs ZIM Integrated Shipping Services Ltd — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while ZIM Integrated Shipping Services Ltd trades at $23.83 (market cap $2.89B). The key difference: ZIM Integrated Shipping Services Ltd pays a 7.88% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, ZIM Integrated Shipping Services Ltd nearer its low. Which is the better fit depends on your goals.
| ARKG | ZIM | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $43.57 | $29.27 |
52-Week Low | $23.09 | $12.44 |
Market Cap | — | $2.89B |
Enterprise Value | — | $6.74B |
Dividend Yield | — | 7.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
ZIM trades at $23.97, down 0.7% on the day, with a bearish technical signal from moving averages. The company reported a Q1 2026 net loss of $86 million, missing EPS expectations, though revenue pressure from lower freight rates may be offset by recent supply chain disruptions. Valuation metrics show a low P/S of 0.46 and P/B of 0.76, suggesting potential undervaluation relative to assets. Key developments include a pending merger with Hapag-Lloyd facing regulatory hurdles and a rival $4.5 billion takeover bid from Haim Sakal.
The outlook for ZIM is clouded by operational challenges and merger uncertainty, but current asset-based valuations provide a floor near $29–$30 per share. Investment opportunity exists if merger approvals proceed or freight rates rebound from Hormuz blockade effects. Primary risks include regulatory rejection of deals, sustained earnings pressure, and high debt-to-asset ratio of 0.71. Analyst consensus is split evenly between Hold and Sell with a $16.75 price target, indicating cautious sentiment amid speculative M&A dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About ZIM Integrated Shipping Services Ltd
ZIM is a global container liner shipping company that employs a 'global-niche' strategy, focusing on specific trade lanes where it holds a competitive advantage. Unlike larger, asset-heavy competitors, ZIM operates an agile, charter-intensive fleet, allowing it to rapidly adjust capacity to market demand while prioritizing digitalization and specialized cargo like refrigerated (reefer) goods.
Read more on ZIM →
